Bronitazene

Bronitazene

Molecular structure via molpic based on CDK

Physical properties []
Molecular mass	431.3 g/mol ^[1]
Predicted LogP	4.6 ^[1]

Structural Identifiers []
Molecular formula	C₂₀H₂₃BrN₄O₂ ^[1]
IUPAC name	2-[2-[(4-bromophenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamine ^[1]
SMILES	CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)Br ^[1]
InChI	InChI=1S/C20H23BrN4O2/c1-3-23(4-2)11-12-24-19-10-9-17(25(26)27)14-18(19)22-20(24)13-15-5-7-16(21)8-6-15/h5-10,14H,3-4,11-13H2,1-2H3 ^[1]
InChIKey	DVPSGKCQADVLCO-UHFFFAOYSA-N ^[1]

Bronitazene (also known as 1H-benzimidazole-1-ethanamine, 2-((4-bromophenyl)methyl)-n,n-diethyl-5-nitro-) is a opioid substance of the nitazene class.

Chemistry

Stereochemistry []

Bronitazene is a achiral mixture.

Subjective effects []

class / Opioid

Physical effects
Constipation Cough suppression Difficulty urinating Itchiness Nausea Pain relief Pupil constriction Respiratory depression Sedation Stomach cramp

Cognitive effects
Anxiety suppression Cognitive euphoria Compulsive redosing Increased music appreciation Thought deceleration

Visual effects
Double vision

External links []

References []

National Center for Biotechnology Information. PubChem Compound Summary for CID 162623726, Bronitazene. Accessed June 7, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/162623726
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Bronitazene. UNII: PGR9Q9X5QW. Global Substance Registration System. Accessed June 7, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/PGR9Q9X5QW

AnodyneWiki